- ►ajph.org [PDF] JB Wong, GM McQuillan, JG … - American Journal of …, 2000 - Am Public Health Assoc John B. Wong is with the Division of Clinical De- cision Making, Informatics and
Telemedicine, De- partment of Medicine, New England Medical Cen- ter, Tupper Research
Institute, Tufts University School of Medicine, Boston, Mass. Geraldine M. McQuil- lan is ... Cited by 370 - Related articles - BL Direct - All 4 versions
GL Davis, JY Lau - Hepatology, 1997 - interscience.wiley.com Alpha interferon is the only drug that has been shown to be effective in the treatment of chronic
hepatitis C, but only half of patients respond, either transiently or permanently. Pretreatment features
that are associated with a greater likelihood of response to short courses of interferon ... Cited by 281 - Related articles - BL Direct - All 3 versions
GL Davis, JE Albright, SF Cook, DM Rosenberg - Hepatology - interscience.wiley.com Chronic hepatitis C virus (HCV) infection is common and often results in slowly progressive liver
disease. Although acute hepatitis C is now uncommon, most patients with acute infection have
developed chronic hepatitis, and, therefore, the pool of infected patients is large. We used ... Cited by 260 - Related articles - BL Direct - All 6 versions
A Freeman, GJ Dore, MG Law, M Thorpe, J Von … - Hepatology, 2001 - interscience.wiley.com To gain a clearer understanding of the rate of progression to cirrhosis and its determinants in
chronic hepatitis C virus (HCV) infection, a systematic review of published epidemiologic studies
that incorporated assessment for cirrhosis has been undertaken. Inclusion criteria were ... Cited by 251 - Related articles - BL Direct - All 3 versions
KL Lindsay - … Development Conference: Management of Hepatitis C, 1998 - consensus.nih.gov 58 Therapy of Hepatitis C: Overview Karen L. Lindsay, MD A great deal has been learned about
the treatment of hepatitis C since the original report describing the use of interferon alfa-2b in
1986. 1 Most of the studies have been done in patients with chronic hepatitis C infection, ... Cited by 225 - Related articles - View as HTML - BL Direct - All 7 versions
A Alberti, L Chemello, L Benvegnų - Journal of Hepatology, 1999 - Elsevier Ten years after the discovery of the hepatitis C virus (HCV) and its association with NANB hepatitis
as a major cause of chronic liver disease worldwide, our knowledge of the natural history of hepatitis
C is still limited. The asymptomatic course of the disease in most patients, its slow and ... Cited by 211 - Related articles - All 11 versions
HL Bonkovsky, JM Woolley - Hepatology (Baltimore, Md.), 1999 - archive.biomedcentral.com The natural history, prognosis, and clinical significance of chronic hepatitis C are highly variable
and somewhat controversial. The purpose of this study was to evaluate the effect of chronic hepatitis
C infection on patients' perceptions of health-related quality of life (HRQOL) and to ... Cited by 206 - Related articles - BL Direct - All 4 versions
F Sarasin, PE Majno, JM Llovet, J Bruix, G Mentha, … - Hepatology, 2001 - interscience.wiley.com Cadaveric liver transplantation (CLT) is an excellent treatment for early hepatocellular carcinoma
(HCC). Its use, however, is limited by the shortage of grafts, with up to 30% of patients developing
contraindications to the procedure while waiting for a donor. Living donor liver ... Cited by 197 - Related articles - BL Direct - All 4 versions
PE Majno, FP Sarasin, G Mentha, A Hadengue - Hepatology, 2000 - interscience.wiley.com Two treatments are accepted for patients with solitary hepatocellular carcinoma 5 cm in size
and with preserved hepatic function: (1) liver resection, which can be performed without delay
but has a high recurrence rate, and (2) liver transplantation, which has a better long-term ... Cited by 163 - Related articles - BL Direct - All 3 versions
JL Dienstag, JG McHutchison - Gastroenterology, 2006 - Elsevier In the United States, hepatitis C virus (HCV) infection accounts for approximately 40% of all chronic
liver disease, results in an estimated 8000–10,000 deaths annually, and is the most frequent
indication for liver transplantation. 1 , 2 , 3 , 4 , 5 , 6 and 7 The Third National Health and ... Cited by 167 - Related articles - All 17 versions
